抗体
试剂盒
多肽
蛋白
组织芯片
产品中心
Product Center
Research Grade Lacnotuzumab
All
TD-HY515016_1.jpg
TD-HY515016_2.jpg
- Catalog： TD-HY515016
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： MCS-110, CAS: 1831128-32-5
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Lacnotuzumab
| Catalog No. | TD-HY515016 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Humanized |
| Isotype | IgG1-kappa |
| Expression system | Mammalian Cells |
| Species | Human |
| Clonality | Monoclonal |
| Target | CSF1, Macrophage colony-stimulating factor 1, CSF-1, Lanimostim, M-CSF, MCSF |
| Endotoxin level | Please contact with the lab for this information. |
| Purity | >95% as determined by SDS-PAGE. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Accession | P09603 |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Alternate Names | MCS-110, CAS: 1831128-32-5 |
| Background | Lacnotuzumab (MCS110) is a neutralizing humanized IgG1/κ monoclonal antibody targeting CSF-1 that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis. |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
|
|
Detects Human CSF1/M-CSF in indirect ELISAs. |
|
|
SDS-PAGE for Research Grade Lacnotuzumab. |